Canaccord Genuity on BioMarin (BMRN): November Data + M&A Speculation = Top Pick
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy/Top Pick' on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) price target of $52.00.
Analyst, Salveen Richter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Salveen Richter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
